Background
==========

Rectal cancer is the 5th leading cause of cancer-related death and its incidence is increasing at a rate of 4.2% per year in China \[[@B1]\]. Early detection and early therapy are important for the control of death caused by rectal cancer.

The majority of epithelial cancers arise through a stepwise progression from normal cells, through dysplasia, into malignant cells that have invasive and metastatic potential. The classic example of this process is the colorectal adenoma to carcinoma progression \[[@B2],[@B3]\]. Genomic aberrations are found frequently in cancers and are believed to contribute to initiation and progression of cancer by deletion-induced down-expression of tumor suppressor genes or amplification and activation of oncogenes. In colorectal cancer the most frequent chromosomal aberrations were gains at 7p, 7q, 8q, 13q, and 20q and losses of 1p, 4p, 4q, 5q, 8p, 14q, 15q, 17p and 18q \[[@B4]-[@B9]\]. In particular, 8q, 13q and 20q gains and 8p, 15q and 18q losses are linked with colorectal adenoma to carcinoma progression. However, most of published reports are focused on colon cancer. Little information is available concerning the genomic aberrations of rectal carcinoma, especially DNA copy number changes in the progression from adenoma to tumor.

In the present study, we investigated the genomic aberrations of rectal adenoma and carcinoma by oligonucleotide-based array CGH, and identified common and different alterated chromosome regions between rectal adenoma and carcinoma. Then the expression of 15 genes at selected chromosome regions above was analyzed by real-time PCR or immunohistochemistry.

Methods
=======

Patients and samples
--------------------

Biopsy tissues from 22 rectal adenoma patients and 36 rectal carcinoma patients were collected by the Department of Endoscopy, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. Biopsy samples were obtained by colonoscopy and stored at −80°C. Definitive pathological result from a biopsy was obtained at a later clinical course. An experienced pathologist confirmed that normal cell content of all the samples was less than 40% by HE staining. All the samples used in this study were residual specimens after diagnosis sampling. And all patients signed separate informed consent forms for sampling and research. The clinicopathological characteristics of the patients in array CGH assay are summarized in Table [1](#T1){ref-type="table"}.

###### 

Clinical Characteristics of 16 Patients Studied by Array CGH

  **Case No.**   **Sex**   **Age**   **Type**    **Location**
  -------------- --------- --------- ----------- --------------
  1              F         52        Adenoma     Rectum
  2              F         49        Adenoma     Rectum
  3              M         75        Adenoma     Rectum
  4              M         47        Adenoma     Rectum
  5              M         57        Adenoma     Rectum
  6              F         61        Adenoma     Rectum
  7              M         69        Adenoma     Rectum
  8              F         75        Adenoma     Rectum
  9              M         69        Carcinoma   Rectum
  10             M         61        Carcinoma   Rectum
  11             F         70        Carcinoma   Rectum
  12             F         73        Carcinoma   Rectum
  13             M         42        Carcinoma   Rectum
  14             M         32        Carcinoma   Rectum
  15             F         31        Carcinoma   Rectum
  16             M         66        Carcinoma   Rectum

Genomic DNA extraction and array-based CGH
------------------------------------------

Genomic DNA was isolated from tumor tissues using the Qiagen DNeasy Blood & Tissue Kit as described by the manufacturer (Qiagen, Hilden, Germany).

Array CGH experiments were performed using standard Agilent protocols (Agilent Technologies, Santa Clara, CA). Commercial human genomic DNA (PROMEGA, Warrington, UK) was used as reference. For each CGH hybridization, 500 ng of reference genomic DNA and the same amount of tumor DNA were digested with Alu I and RSA I restriction enzyme (PROMEGA, Warrington, UK). The digested reference DNA fragments were labeled with cyanine-3 dUTP and the tumor DNA with cyanine-5 dUTP (Agilent Technologies, Santa Clara, CA). After clean-up, reference and tumor DNA probes were mixed and hybridized onto Agilent 44K human genome CGH microarray (Agilent) for 40 h. Washing, scanning and data extraction procedures were performed following standard protocols.

Array CGH data set is available at Gene Expression Omnibus (GEO) <http://www.ncbi.nlm.nih.gov/geo/>\[[@B10]\], accession number GSE34472.

Microarray data analysis
------------------------

Microarray data were analyzed using Agilent Genomic Workbench (Agilent Technologies, Santa Clara, CA) and MD-SeeGH (<http://www.flintbox.ca>). The Aberration Detection Method 2 algorithm with threshold at 6 (Agilent Genomic Workbench) was applied to identify common genomic aberrations. Mean Log2^ratio^ of all probes in a chromosome region between 0.125 and 0.5 was classified as genomic gain, \> 0.5 as high-level DNA amplification, \< −0.125 as hemizygous loss, and \< −0.5 as homozygous deletion. Minimal regions of gains or losses in our study defined as the smallest overlapping aberrant chromosomal regions identified by Agilent Genomic Workbench. Frequency plot comparison method (MD-SeeGH) was used to compare frequency of DNA copy number changes between rectal adenoma and carcinoma.

Total RNA extraction and real-time PCR
--------------------------------------

Total RNA was isolated from tissues using the RNeasy Mini Kit as described by the manufacturer (Qiagen, Hilden, Germany).

The PCR reactions were performed in a total volume of 20 μl, including 10 μl of 2 X SYBR ® Green PCR Master Mix (Applied Biosystems, Warrington, UK), 2 μl of cDNA (5 ng/μl), 1 μl of primer mix (10 μM each). The PCR amplification and detection were carried out in a 7300 Real Time PCR System (Applied Biosystems) for 45 cycles, each with 15 s at 95 °C, 1 min at 60 °C, and initial denaturation with 10 min at 95 °C. The relative gene expression was calculated using the comparative CT Method \[[@B11]\]. The copy number of the target gene normalized to an endogenous reference (GAPDH), and relative to calibrator was given by the formula 2 − ΔΔCt. ΔCT was calculated by subtracting the average GAPDH CT from the average CT of the gene of interest. The ratio defines the level of relative expression of the target gene to that of GAPDH.

Immunohistochemical staining
----------------------------

Formalin-fixed, paraffin-embedded specimens of rectal adenoma and carcinoma were detected in immunohistochemistry assay. Tissues of each case were repeated for three times. The slides were deparaffinized, rehydrated, immersed in 3% hydrogen peroxide solution for 10 min, heated in citrate buffer (pH 6) for 25 min at 95°C, and cooled for 60 min at room temperature. The slides were blocked by 10% normal goat serum for 30 min at 37°C and then incubated with rabbit polyclonal antibody against DIS3 (PTGLab), rabbit polyclonal antibody against GPNMB (PTGLab) overnight at 4°C. After being washed with PBS, the slides were incubated with biotinylated secondary antibody (diluted 1:100) for 30 min at 37°C, followed by streptavidin-peroxidase (1:100 dilution) incubation for 30 min at 37°C. Immunolabeling was visualized with a mixture of 3,3\'-diaminobenzidine solution. Counterstaining was carried out with hematoxylin.

Expression level was determined on the basis of staining intensity and percentage of immunoreactive cells. Negative expression (score = 0) was no or faint staining, or moderate to strong staining in \<25% of cells. Weak expression (score = 1) was a moderate or strong staining in 25% to 50% of cells. And strong expression (score = 2) was \> 50% of the cells with strong staining. Weak expression and strong expression defined as positive staining.

Statistical analysis
--------------------

Statistical analyses were conducted using the Student's t-test and performed with the statistical software SPSS 15.0. The differences were judged as statistically significant when the corresponding two-sided P value were \<.05.

Results
=======

Recurrent copy number alterations in rectal adenoma and carcinoma detected by array CGH
---------------------------------------------------------------------------------------

Seven out of eight adenomas and all of carcinomas had genomic aberrations. More alterations were observed in patients of rectal cancer than adenoma, and the numbers of changes were 39.13±20.48 and 14.3±6.164, respectively (Additional file [1](#S1){ref-type="supplementary-material"}: Figure S1). Array CGH results showed that the most frequent copy number alterations in rectal adenoma were gains of 7p21.3-p15.3 and 20p12.3-p11.21 and losses of 5q13.2, 7q11.23, 11q13.1-q14.1, 17q25.1 and 19p13.3-p13.11 (Figure [1A](#F1){ref-type="fig"}, Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}). And the most common genetic aberrations in rectal carcinoma were gains of 7p21.3-p15.3, 7p15.3-p14.1, 7p14.1-p13, 7p13-p11.2, 13q13.1-q14.11, 13q21.1-q32.1, 13q32.1-q34, 20p11.21, 20q11.23-q12 and 20q13.2-q13.33 and losses of 17p13.1-p11.2, 18p11.32-p11.21 and 18q11.1-q11.2 (Figure [1B](#F1){ref-type="fig"}, Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

![**Genome-wide frequency plot of rectal adenoma (A) and adenocarcinoma (B) in array CGH assay.** Line on the right of 0%-axis: gain; Line on the left of 0%-axis: loss.](1755-8794-5-52-1){#F1}

###### 

Genomic Gains in Rectal Adenoma and Adenocarcinoma

  --------------------------------------------------------------------------------------------------------------------
  **Chromosome Region**   **Rectal adenoma**   **Rectal adenocarcinoma**                                           
  ----------------------- -------------------- --------------------------- ----- --- ----------- ----------- ----- ---
  1q21.3                                                                             150819451   150852905   3     3

  1q25.3-q31.3                                                                       183720174   197184608   157   3

  1q32.1-q41                                                                         204180950   214439909   173   3

  5p13.3-p12                                                                         33503866    45681293    165   3

  6p21.33-p21.31                                                                     30737615    33655570    151   4

  6q16.3-q27              100547312            168205989                   848   2                                  

  7p21.3-p15.3            11041844             23202043                    119   4   7671318     23172047    142   5

  7p15.3-p14.1                                                                       23821348    39813908    231   5

  7p14.1-p13                                                                         40099046    44497196    64    5

  7p13-p11.2                                                                         44890654    55242365    111   5

  7q21.11-q21.12          81196827             86205180                    42    2                                  

  7q21.12-q21.3                                                                      87207024    97321855    144   4

  7q22.3-q32.1            106191096            127234809                   245   2   105253205   127519635   260   4

  8q12.1                                                                             59565778    61340797    21    3

  8q24.21-q24.22                                                                     128816904   133653633   42    3

  9p24.1-p21.1                                                                       7058096     31463899    251   4

  11p15.5                                                                            192958      2278596     76    4

  11q13.2                                                                            66917525    67689856    30    4

  12p13.31-p11.21         9053548              30700931                    337   2                                  

  12q12-q13.11            37052371             47174877                    139   2                                  

  12q13.13                                                                           50568352    51486634    34    4

  12q14.1-q22             57350276             91428773                    354   2                                  

  13q13.1-q14.11\         21038984             109780488                   909   2   32490193    39679219    79    7
  13q21.1-q32.1\                                                                                                   
  13q32.3-q34                                                                                                      

                                                                                     52774228    94079000    275   7

                                                                                     100091512   114022929   148   7

  19p13.2-p13.11                                                                     9800520     19631574    473   3

  19q13.13-q13.33                                                                    43396893    55615310    550   3

  20p11.21                7296794              23132344                    189   3   22510206    23380542    15    8

  20q11.23-q12            29592072             42681834                    275   2   35467169    41087006    78    7

  20q13.2-q13.33                                                                     52017030    62323759    215   7
  --------------------------------------------------------------------------------------------------------------------

Note: The number of rectal adenoma and adenocarcinoma in Array CGH study are both 8 cases.

###### 

Genomic Losses in Rectal Adenoma and Adenocarcinoma

  **Chromosome Region**   **Rectal adenoma**   **Rectal adenocarcinoma**                                           
  ----------------------- -------------------- --------------------------- ------ --- ---------- ----------- ----- ---
  1p36.23-p36.22                                                                      7804415    11633739    82    3
  1p36.22-p36.13                                                                      12600054   16167534    41    3
  1p36.12-p35.3                                                                       21802142   29525663    226   3
  1q21.2-q21.3            148163183            149505863                   60     2                                 
  1q21.3-q23.1            151880217            155031244                   154    2                                 
  4q12                    55913547             57653302                    38     2                                 
  5p15.33-p12             260981               45865412                    433    2                                 
  5q13.2                  68434643             68900029                    18     3                                 
  7p22.2-p22.1            4298590              6547570                     42     2                                 
  7q11.23                 72003839             75977276                    77     3                                 
  7q22.1                  99538250             101895994                   79     2                                 
  8q22.2-q24.3            100781187            143914353                   448    2                                 
  8q24.3                  143914353            146250824                   75     2                                 
  9q34.11                 130111425            132321365                   64     2                                 
  10p14-p11.21                                                                        11825924   35645512    315   3
  11p15.2-p11.12          14750051             50638829                    468    2                                 
  11q13.1-q14.1           63802950             80046693                    442    4                                 
  12q24.23-q24.33         116956235            132193660                   257    2                                 
  14q12-q21.1                                                                         30209271   38927323    130   3
  14q22.1-q24.3                                                                       48874529   77750644    544   3
  14q31.3-q32.1                                                                       87763614   93260389    110   3
  14q32.2-q32.32                                                                      99254905   102592287   70    3
  15q15.1-q21.1                                                                       38653893   42843706    119   3
  15q22.31                                                                            61519869   64628895    74    3
  15q25.1-q25.2                                                                       76206143   79967204    77    3
  17p13.1-p11.2           84287                21386319                    606    2   8327645    20974722    266   4
  17q25.1                 70528777             71603516                    61     3                                 
  18p11.32-p11.21         170229               13875315                    173    2   2580000    13752309    137   5
  18q11.1-q11.2           16904187             76018409                    684    2   16976046   20313378    51    4
  19p13.3-p13.11          1432408              19699544                    795    4                                 
  19q13.11-q13.43         37554715             63672832                    1114   2                                 
  20q13.33                60039825             62320720                    85     2                                 
  22q13.1                 37689058             37715431                    3      2                                 

Note: The number of rectal adenoma and adenocarcinoma in Array CGH study are both 8 cases.

Common and distinct genomic events in rectal adenoma and carcinoma
------------------------------------------------------------------

By comparing the genomic aberrations of rectal adenoma and carcinoma, we found that gains of 7p21.3-p15.3, 7q22.3-q32.1, 13q13.1-q14.11, 13q21.1-q32.1, 13q32.3-q34, 20p11.21 and 20q11.23-q12 and losses of 17p13.1-p11.2, 18p11.32-p11.21, and 18q11.1-q11.2 were shared by rectal adenoma and carcinoma. However, gains of 1q, 6p21.33-p21.31 and losses of 10p14-p11.21, 14q12-q21.1, 14q22.1-q24.3, 14q31.3-q32.1, 14q32.2-q32.32, 15q15.1-q21.1, 15q22.31 and 15q25.1-q25.2 were detected in carcinoma but not in adenoma (Figure [2](#F2){ref-type="fig"}, Tables [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}).

![**Frequency plot comparison of rectal adenoma and carcinoma.** Red: carcinoma; green: adenoma; yellow: shared by both. The presentation is per array probe; gains and losses are represented by the colors on the right and left, respectively. Vertical blue line represents 100% of the samples. Brown and blue arrows highlight the changed chromosomal areas that were common or distinct between rectal adenoma and carcinoma, respectively.](1755-8794-5-52-2){#F2}

Candidate target genes of interesting gains and losses
------------------------------------------------------

Further, we selected 14 genes of 1q, 6p, 7p, 13q, 18q and 20q to analyze the mRNA expression by real-time PCR (Table [4](#T4){ref-type="table"}). Array CGH found that copy number increase of GPNMB (7p15.2), OXGR1 (13q32.1), C13orf27 (13q32.2-q34), PMEPA1 (20q13.31), PHACTR3 (20q13.32) and decrease of SMAD4 (18q21.2), BCL2 (18q21.33) occurred in both rectal adenoma and carcinoma. Our real-time PCR results showed that C13orf27 and PMEPA1 were overexpressed in rectal cancer tissues comparing with paracancerous normal tissues. BCL2 and SMAD4 were underexpressed in tumor tissue (Figure [3A](#F3){ref-type="fig"}). And the expression level of C13orf27 and GPNMB was significantly higher in cancer tissues than rectal adenoma tissues (Figure [3B](#F3){ref-type="fig"}).

###### 

Primers of genes in Real-time PCR assay

  **Gene**   **Forward primer**       **Backward primer**       **Size (bp)**
  ---------- ------------------------ ------------------------- ---------------
  GAPDH      GGTCGTATTGGGCGCCTGGTC    TGACGGTGCCATGGAATTTGCCA   148
  KIFC1      TCTCTGGGTGGTAGTGCTAAGA   TAAGTCACTTCCTGTTGGCCTG    148
  SOX4       GACCGGGACCTGGATTTTAACT   TGAAAACCAGGTTGGAGATGCT    133
  PBX2       AAGTTCCAAGAGGAGGCAAACA   TCCTGAGAGATTGAAAGAGCCG    132
  ESRRG      GCTATCCTGCAGCTGGTAAAGA   GCTATCCTGCAGCTGGTAAAGA    133
  KDM5B      CCCTCAGACACATCCTATTCCG   CAGTCCACCTCATCTCCTTCTG    101
  PTGS2      TGTATCCTGCCCTTCTGGTAGA   AAGGAGAATGGTGCTCCAACTT    85
  EFNA1      GTGGCAAAATCACTCACAGTCC   CTATGTAGAACCCGCACCTCTG    91
  BCL2       AGGATTGTGGCCTTCTTTGAGT   CGGTTCAGGTACTCAGTCATCC    113
  SMAD4      TGTTGATGACCTTCGTCGCTTA   ATGCTCTGTCTTGGGTAATCCG    81
  PHACTR3    TATGACAGGAGGGCAGACAAAC   GCTTGCTTGATGCATGTACCTC    118
  C13orf27   TCAGGCTCAGCAGATGAAATGT   TCCAGTGGATTTTATGGGGAGC    85
  PMEPA      CTGAGCCACTACAAGCTGTCTG   CTTCTGAGGACAGGGCATCTTC    85
  OXGR1      ATCTTGAGGGTCATTCGGATCG   TGTCGCTGACCACCACATATAG    148
  GPNMB      GTCACTGTGATCTCCCTCTTGG   TTTGCACGGTTGAGAAAGACAC    116

![**Expression of genes which were located on the common aberrant chromosomal regions in rectal adenoma and carcinoma**. N: paracancerous normal tissues; T: rectal cancer tissues.](1755-8794-5-52-3){#F3}

Copy number increase of EFNA1 (1q22), PTGS2 (1q31.1), KDM5B (1q32.1), ESRRG (1q41), KIFC1 (6p21.32), PBX2 (6p21.32) and SOX4 (6p22.3) were only detected in rectal cancer in array CGH. Among them, EFNA1 had increased expression in carcinoma compared with adenoma, and KIFC1 had an upward trend but not significant in statistical analysis (Figure [4A](#F4){ref-type="fig"}). Of these genes KIFC1 and SOX4 were also significantly overexpressed in rectal tumor tissues than paracancerous tissues (Figure [4B](#F4){ref-type="fig"}).

![**Expression of genes which were located on the distinct aberrant chromosomal regions in rectal adenoma and carcinoma.** N: paracancerous normal tissues; T: rectal cancer tissues.](1755-8794-5-52-4){#F4}

We also analyzed the protein expression of GPNMB (7p15.2) and DIS3 (13q22.1) by immunohistochemistry. Of all six detected rectal adenoma tissues, GPNMB and DIS3 had no expression. In twenty rectal cancer tissues, GPNMB and DIS3 were positively stained in six and five cases, respectively (Figure [5](#F5){ref-type="fig"}).

![Expression of GPNMB and DIS3 by immunohistochemistry assay.](1755-8794-5-52-5){#F5}

Discussion
==========

In the past decades, a number of genomic changes were found in colorectal adenoma and carcinoma, but the target genes are limited and molecular mechanism of adenoma to carcinoma progression is still unknown.

Previous studies found that 8q, 13q and 20q gains and 8p, 15q and 18q losses are linked with colorectal adenoma to carcinoma progression \[[@B4]-[@B9]\]. Our study narrowed down the gain regions to 13q13.1-q14.11, 13q21.1-q32.1, 13q32.2-q34 and 20q11.23-q12 and the loss regions to 18q11.2. Furthermore, gains of 7p21.3-p15.3 and 7q22.3-q32.1 and losses of 17p13.1-p11.2, 18p11.32-p11.21 were also found in both rectal adenoma and carcinoma.

Our study also showed that some genomic aberrations were present in rectal tumor but not in adenoma. They are gains of 1q and 6p21.33 and losses of 10p14-p11.21, 14q12-q21.1, 14q22.1-q24.3, 14q31.3-q32.1, 14q32.2-q32.32, 15q15.1-q21.1, 15q22.31 and 15q25.1-q25.2. These aberrations occurred at the later stages of rectal carcinogenesis, and may contribute the progression from adenoma to carcinoma.

Identifying the candidate targets underlying the genomic aberrations was important for understanding the mechanism of carcinogenesis. Carvalho et al. found that the overexpressions of C20orf24, AURKA, RNPC1, TH1L, ADRM1, C20orf20 and TCRL5 in carcinomas compared with adenomas were correlated with 20q gain \[[@B4]\]. Habermann et al. showed that copy number changes of 7q, 8p, 8q, 13q, 18p, 18q, 20p and 20q deregulated the average expression levels of the genes on these chromosome arms \[[@B12]\]. However, most of samples detected in these reports were colon cancer which had some different genomic aberrations compared with rectal cancer \[[@B13]\], expression-dysregulated genes in the carcinogenesis of rectum were still limited. By literature analyses, we selected 14 genes to compare their expression between in tumor and paracancerous tissues or between in rectal adenoma and carcinoma tissues. Of them, copy number and mRNA expression of EFNA1 increased from rectal adenoma to carcinoma, and C13orf27 and PMEPA1 with gains in both adenoma and carcinoma were overexpressed in rectal cancer tissues. These results revealed that copy number increase maybe the reason of expression up-regulation. Interestingly, both mRNA and protein expression of GPNMB was higher in cancer tissues than rectal adenoma tissues.

GPNMB is a type I transmembrane protein and overexpressed in several malignant human tissues relative to the corresponding normal tissues. Ectopic overexpression of GPNMB/osteoactivin can promote the metastasis and invasion of glioma, breast and hepatocellular carcinoma \[[@B14]-[@B17]\]. EFNA1 was overexpressed in hepatocellular carcinoma and can inhibit growth of malignant mesothelioma by phosphorylating EPHA2 \[[@B18],[@B19]\]. C13orf27 was overexpressed in rectal tumor in our study, but the function of C13orf27 was unknown. PMEPA1 was also identified in our study, which is mapped to 20q13.3 is a TGF-beta inducible gene and encodes a NEDD4 E3 ubiguitin ligase binding protein. PMEPA1 is over-expressed in prostate, breast, renal cell, stomach and rectal carcinomas \[[@B20]-[@B22]\]. But little is known about the function of PMEPA1, Further study should be conducted to investigate the roles of the above genes in human colorectal cancer.

Loss of 18q is a common event in colorectal cancer, and 18q deletion and loss of SMAD4 expression are associated with liver metastasis. In colorectal cancer, patients with reduced SMAD4 expression frequently presented an unfavorable survival because of liver metastasis \[[@B23]-[@B26]\]. High expression level of SMAD4 reflected significantly longer overall and disease-free survival time than low expression level \[[@B27]\]. Bixiang et al. found that transgenic expression of SMAD4 can significantly reduce the oncogenic potential of MC38 and SW620 cells \[[@B28]\]. Our study confirmed the decreased expression of SMAD4 in rectal cancer.

In summary, we identified [EFNA1 (1q)]{.ul}, C13orf27 (13q), PMEPA1 (20q), [GPNMB (7q)]{.ul} as candidate driving genes of genomic aberrations in rectal cancer. Further study was needed to reveal the mechanisms by which these genes may be involved in the carcinogenesis of the rectum.

Conclusions
===========

Our data provide detailed information on genomic aberrations present in rectal adenoma or carcinoma, especially both in two groups or only in rectal cancer. Real-time PCR and immunohistochemistry assay selected EFNA1, C13orf27, PMEPA1 and GPNMB as candidate amplification targets. Our results may help to identify the driving genes involved in the adenoma-carcinoma progression.
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